Association between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure with Reduced Ejection Fraction

OBJECTIVE: Our objective is to describe the short-term, health status benefits of ARNI initiation in patients with heart failure and reduced ejection fraction (HFrEF). BACKGROUND: While sacubitril/valsartan, a neprilysin inhibitor (ARNI), improved patients’ health status (compared with enalapril) at...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JACC Heart Fail
Huvudupphovsmän: Khariton, Yevgeniy, Fonarow, Gregg C., Arnold, Suzanne V., Hellkamp, Ann, Nassif, Michael E., Sharma, Puza P., Butler, Javed, Thomas, Laine, Duffy, Carol I, DeVore, Adam, Albert, Nancy M., Patterson, J. Herbert, Williams, Fredonia B., McCague, Kevin, Spertus, John A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7122134/
https://ncbi.nlm.nih.gov/pubmed/31521679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2019.05.016
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk